24 research outputs found
Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.
<p>Mean hemoglobin values during treatment with PR+TVR stratified by ITPA deficiency.</p
Hemoglobin decline at week 4 of therapy and management of anemia stratified by ITPA deficiency.
<p>*No ITPA deficiency vs any ITPA deficiency.</p
Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).
<p>Degrees of ITPA deficiency according to rs1127354/rs7270101 genotypes combinations (0–3: no ITPA deficiency, mild, moderate or severe deficiency).</p
Cirrhosis Discriminate Score (CDS) calculation.
<p>Cirrhosis Discriminate Score (CDS) calculation.</p
Non-invasive tests (NITs) values distribution at baseline and after an SVR.
<p>Non-invasive tests (NITs) values distribution at baseline and after an SVR.</p
Non-invasive tests (NITs) values before and after treatment.
<p>Non-invasive tests (NITs) values before and after treatment.</p
Median<sup>#</sup> NIT values at post-SVR liver biopsy and reference cut-offs for the diagnosis of cirrhosis.
<p>Median<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155967#t003fn001" target="_blank"><sup>#</sup></a> NIT values at post-SVR liver biopsy and reference cut-offs for the diagnosis of cirrhosis.</p
Patients' characteristics at the time of post-SVR liver biopsy.
<p>Patients' characteristics at the time of post-SVR liver biopsy.</p
Non-invasive Tests (NITs) values stratification according to post-SVR fibrosis stage.
<p>Non-invasive Tests (NITs) values stratification according to post-SVR fibrosis stage.</p